Skip to main navigation menu Skip to main content Skip to site footer

Ulcers due to gout: Presentation of a case and literature review

Úlceras por gota: Presentación de un caso y revisión de la literatura




Section
Review Articles

How to Cite
Hernández, J. I., Bonilla, C. E., & López, J. F. (2004). Ulcers due to gout: Presentation of a case and literature review. Journal of Medicine and Surgery Repertoire, 13(2), 61-66. https://doi.org/10.31260/RepertMedCir.v13.n2.2004.344

Dimensions
PlumX
license

   

José Ignacio Hernández
    Carlos Eduardo Bonilla
      José Fernando López

        Gout is a well-known disease and within its wide spectrum of signs and symptoms, there are some that have rarely been documented; Such is the case that we present today. It is a patient with gout who suffers ulcers in the lower limbs of long evolution. When being known in the internal medicine service of this institution, a biopsy of the lesions described is performed, confirming panniculitis due to gout, this being the fifth case reported in the world literature.


        Article visits 582 | PDF visits 1445


        Downloads

        Download data is not yet available.

        1. Gerstner, J. Glosario. Rev. Col. Ort Tra. 2002; 16.

        2. Kramer HM, Curgan G The association between gout and nephrolithiasis: the nacional health and nutrition examination survey III, 1988-1994. Am. J Kidney Dis 2002; 4: 37-42

        3 Emmerson B, Word A. The Management of Gout. The N Engl J Med 1996; 334 (7): 446-51.

        4. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative aging study. Am J Med 1987; 82: 421-26.

        5. Lin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout. J Rheumatol 2000; 27: 1045-1050.

        6. Waller PC, Ramsay LE. Predicting acute gout in diuretic - treated hypertensive patients. J Hum Hypertens 1989; 3: 457-61.

        7. Kelley ' s Reumatologia. Sinovitis por depósito de Cristales. Gota e hiperuricemia. 2003, Madrid, España: v.3 p.1339-76.

        8. Bulla F, Restrepo J F, Iglesias A., Palma, F. Paniculitis por gota. Rev Col Reum 2000:7 (4): 391-95.

        9. Wortmann RL. Gout and Hyperuricemia. Curr Opin Rheumatol 2002; 14:281-86.

        10. Schlesinger N, Schumacher HR Jr. Gout: can management be improved?. Curr Opin Rheumatol 2001; 13:240-44.

        11. Durán R, Altahona H, Hernández J.I, Barreto F.J. Seminarios en Medicina Interna. Bogotá; Universidad del Rosario, 1995; 420.

        12. Wallace SL, et al. Preliminary criteria for the classiflcation of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.

        13. Terkeltaub R A Gout. N. Engl J Med 2003, 349 (17): 1647-55.

        14. Terkeltaub RA. Pathogenesis and treatment of crystal induced inflammation. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of Rheumatology. 14 th ed. Philadelphia: Lippincot Williams & Wilkins, 2001; v 2; p. 2329-47.

        15. Schlesinger N, Detry MA, Holland BK et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002; 29:331-34.

        16. Axelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31:803-05.

        17. Siegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetinide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-27.

        18. Emmerson, B. The Management of Gout. N England J Med 1996; 334 (7): 445-51.

        19. Ferraz MB. An evidence based appraisal of the management of nontophaceous interval gout. J Rheumatol 1995; 22: 1618-19.

        20. Insel P. Analgésicos - Antipiréticos, antiinflamatorios y fármacos Antigotosos. En: Goodman & Gilman's Las Bases Farmacológicas de la Terapéutica,. 9' ed. McGraw-Hill Interamericana. v. 1 p 661-705.

        21. Pérez-Ruiz F, Calabozo M, Pijoan JI, Herrero AM, RUibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47:356-60.

        22. Shahinfar S, Simpson RL, Carides AD et al. S afety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int 1999;56:1879-85.

        23. Sica DA, Schoolwerth AC. Uric Acid and losartan. Curr Opin Nephrol Hypertens 2002; 11:475-82.

        24. Wurzner G, Gerster JC, Chiolero A, et al. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001; 19 (10):1855-60.

        25. Bomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Uricase formulated with poyetiethylene glycol (Uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol 2002; 29:1942-49.

        26. Hepburn AL, Kaye SA, Fcher Fenofibrate: a new treatment for hyperuricaemia and gout?. Ann Rheum Dis 2001; 60(10):984-6.

        27. Yamamoto T, Moriwaki Y, Takahashi S, et al. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol. J Rheumatol. 2001; 28 (10): 229497.

        28. Hardin T. Fenofibrate and losartan. Ann Rheum Dis, 2003; 62 (6): 497-98.

        29. HepbumAL, Feher Gout. N Engl J Med, 2004; 350 (5): 519-20.

        30. Niemi, K M. Panniculitis of the legs with urate cristal deposition. Archi Dermatol 1977; 113: 655-6.

        31. Le Boit PE, Schneider S. Gout presenting as lobular panniculitis. Am. J Dermatopathol. 1987; 9:334-38.

        32. Conejo-M J, Pulpillo, A et al. Panniculitis and ulcers in a young man. Arch Dermatol 1998; 134: 499-504.

        Sistema OJS 3.4.0.5 - Metabiblioteca |